In 2012, it was demonstrated that EVs containing miR-21 and miR-29a released by non-small cell lung cancer cell lines were targeting tumor-associated macrophages and, more specifically, the human toll-like receptor 8 (TLR8), triggering the downstream pathway. Here, TLR8 is linked to non-small cell lung carcinoma.